|
|||||
|
|
Impact of metformin use on the cardiovascular effects of dipeptidyl peptidase-4 inhibitors: An analysis of Medicare claims data from 2007 to 2015 |
|
| Authors: | Matthew J. Crowley MD Mugdha Gokhale PhD Virginia Pate MS Til Stürmer MD John B. Buse MD |
| Affiliation: | 1. Center for Health Services Research in Primary Care, Durham VAMC, Durham, North Carolina;2. Real World Evidence and Epidemiology, GlaxoSmithKline, Collegeville, Pennsylvania;3. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina;4. Department of Medicine, Division of Endocrinology and Metabolism, University of North Carolina, Chapel Hill, North Carolina |
| Abstract: | |
| Keywords: | cardiovascular disease DPP-4 inhibitor metformin pharmaco-epidemiology type 2 diabetes |